Exchange: NYSE·Updated 07:32 PM EDT

ATR News

News
all
press releases
AptarGroup (ATR) Loses 5.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
AptarGroup (ATR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Zacks
AptarGroup (ATR) Loses 5.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
AptarGroup (ATR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Zacks
More News
Zacks Industry Outlook Highlights Avery Dennison, AptarGroup and Karat Packaging
AVY, ATR and KRT are navigating weak packaging demand with pricing, cost controls and growth in e-commerce and eco-friendly products.
Zacks
3 Packaging Stocks Worth Watching Despite Industry Pressure
Although weak demand and tariffs cloud the Zacks Containers - Paper and Packaging industry's near-term outlook, AVY, ATR and KRT are navigating the challenges well.
Zacks
Aptar Pharma and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery
AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that it has signed an agreement for a research collaboration led by Alice Stanton, PhD from Massachusetts General Hospital (MGH) to advance the science...
Business Wire
AptarGroup Breaks Below 200-Day Moving Average - Notable for ATR
In trading on Tuesday, shares of AptarGroup Inc. (Symbol: ATR) crossed below their 200 day moving average of $126.52, changing hands as low as $125.00 per share. AptarGroup Inc. shares are currently trading off about 1.4% on the day. The chart below shows the one year performa...
Nasdaq News: Markets
WST Stock Surges 38.1% Since March-End: What's Fueling the Rally?
West Pharmaceutical Services has surged 38.1% since March-end as HVP demand, GLP-1 growth and productivity gains fuel the rally.
Zacks
WST Gains 15.3% in Three Months as HVP Growth Strengthens Outlook
WST's HVP growth, wider margins and raised 2026 outlook support its recent rally, but a premium valuation raises the bar for further gains.
Zacks
AptarGroup Q2 Earnings Beat Estimates on Pharma & Beverage Growth
ATR tops Q2 earnings and revenue estimates as pharma and beverage growth lift quarterly revenues above $1B for the first time despite margin pressure.
Zacks
Why AptarGroup (ATR) International Revenue Trends Deserve Your Attention
Review AptarGroup's (ATR) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
Zacks
AptarGroup (ATR) Tops Q2 Earnings and Revenue Estimates
AptarGroup (ATR) delivered earnings and revenue surprises of +5.97% and +2.32%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks

Advertisement|Remove ads.